Fierce Pharma Week - PR & Communications

Trust Is Built Long Before a Headline

In an era of heightened scrutiny, evolving stakeholder expectations, and a rapidly changing media landscape, communications leaders play a critical role in shaping reputation, building credibility, and driving organizational influence. Fierce Pharma Week delivers the insights, strategies, and peer perspectives needed to strengthen trust, navigate change, and shape the conversations that matter most.

See Who's Already Registered...

Here's a small sample of attendees already registered from the PR & Communications Community for 2026!

VP Investor Relations, Agios Pharmaceuticals
Chief Corporate Affairs Officer, Amicus Therapeutics
Senior Lead, Corporate Digital Strategy and Brand, Boehringer Ingelheim
Chief Communications Officer, Invivyd Inc.
Senior Director, US Media & Stakeholder Relations, Novo Nordisk
Head of Corporate Affairs, Servier Pharmaceuticals
Senior Director, Corporate Communications, Agios Pharmaceuticals
Head of R&D Communications, Astellas Pharma Inc.
SVP Corporate Affairs, Cullinan Therapeutics
Head of Communications, Keenova
Associate Director Corporate Communications, Phathom Pharmaceuticals
VP of Corporate Communications, Sionna Therapeutics

Integrated Communications Lead Cardiovascular/Renal + Stroke, Bayer
Senior Director Patient Advocacy, Cullinan Therapeutics
Executive Director Corporate Communications, Madrigal Pharmaceuticals
VP, Corporate Communications, Phathom Pharmaceuticals
VP, Global Commercial Communications, Zoetis
Manager Amgen Media Relations, Amgen
SVP Corporate Affairs HP US and President Boehringer Cares Foundation, Boehringer Ingelheim
SVP Global Communications & Corporate Affairs, Genmab
President and CEO, National Pharmaceutical Council (NPC)
Head of Corporate Communications for Global Oncology, Sanofi

The Ideas, Strategies & Trends Defining PR & Communications

Dive into 2 specialized tracks designed to help navigate today's biggest challenges and opportunities.

 

Enterprise Strategy, Reputation, & Risk

Explore how communications shape business strategy, strengthen corporate credibility, and influence high-stakes decision-making.

 

Audience Engagement, Media & Brand

Discover how communications connect with key audiences, build trust, and drive influence across an evolving media and stakeholder landscape.

Key Topics Covered in the PR & Communications Community

 

Corporate & Brand Reputation:

Focuses on building, maintaining, and protecting a company’s reputation in a competitive and often skeptical landscape. Sessions explore brand positioning, corporate responsibility, DEI communications, and strategies to safeguard trust during crises and political shifts

 

0
FPW25-PR-Photo-5.png

 

Strategic Product Communication:

Explores how to effectively communicate product value across stakeholder groups—including patients, media, and HCPs—while reinforcing broader corporate messaging. Sessions will cover tactics to build trust, drive awareness, and position products competitively in an evolving marketplace.

 

0
FPW25-PR-Photo-2.png

 

Evolving Media & Technology Trends:

Examines how technology like AI and social media are reshaping communication strategies and risk management. This track will address misinformation, deepfakes, and how to integrate emerging tools to stay ahead of trends without losing the human element

 

0
FPW25-PR-Photo-11.png

Stakeholder Relationship Management:

Highlights strategies for building transparent, meaningful relationships with investors, employees, patients, and community voices. This track dives into investor relations, patient engagement, and the role of communicators in guiding C-suite decisions that shape corporate reputation and value.

 

0
FPW25-PR-Photo-7.png

 

Fierce Pharma Week 2025 by the Numbers

4
Engaged Communities
17
Targeted Tracks
200+
Can't Miss Sessions
400+
Expert Speakers
3000+
Pharma Leaders in One Place

Let's work together!

Find out why Fierce Pharma Week is the ultimate networking opportunity to reach key decision makers across every corner of the biopharma ecosystem.